No insider purchase over the last 90 days. The latest, by 하기완, was filed 02 Jun 2026.
Raphas Co., Ltd.: what insiders have been doing
Raphas Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 22 October 2025 to 22 October 2026, the disclosure feed for Raphas Co., Ltd. logged 6 filings by 3 insiders.
No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €264k, made by 2 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €206k by 정도현, published on 12 May 2026, equal to 0.50% of the market capitalisation. On the buying side, the filings list 1 chief executive among the declarants.
Compared with its exchange (2,650 companies, median 7 filings), a count of 6 filings is below the norm. Looking back to 2021, when coverage begins, insiders filed 10 purchases and 37 sales.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 2 June 2026, 161 days ago. The median gap between a trade and its publication by DART (FSS) is 1 day. That lag is the time during which only the insider knows about the trade.
This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +3.4%Entry ₩6,790 · Close 21 Oct 2026 ₩7,020
- -18.0%Entry ₩8,560 · Close 21 Oct 2026 ₩7,020
- -34.4%Entry ₩20,550 · Close at T+365 ₩13,490
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,136 shares@ ₩7,552.42960.011% mcap100.0% of flowShareKRXDART:20260602000266Canonical exit: 20 Aug 2026 (T+90)
- 10,030 shares@ ₩9,253.43770.13% mcap20.6% of flowShareKRXDART:20260512000158Canonical exit: 9 Aug 2026 (T+90)
- 42,030 shares0.50% mcap79.4% of flowKRXDART:20260512000227Canonical exit: 9 Aug 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 500 sharesKRXDART:20250609000055
- 500 sharesShareKRXDART:20250609000046
- 97,260 sharesKRXDART:20250124000668
- 97,260 sharesShareKRXDART:20250124000659
- 71,600 sharesKRXDART:20241220000490
- 74,600 sharesShareKRXDART:20241220000471
- ShareKRXDART:20241220000543
- ShareKRXDART:20241007000165Canonical exit: 26 Dec 2024 (T+90)
- 0KRXDART:20240923000041
- ShareKRXDART:20240820000036Canonical exit: 18 Nov 2024 (T+90)
- 20,970 sharesKRXDART:20240705000408
- ShareKRXDART:20240705000402
- ShareKRXDART:20240702000015Canonical exit: 30 Sept 2024 (T+90)
- ShareKRXDART:20240628000077Canonical exit: 26 Sept 2024 (T+90)
- ShareKRXDART:20240627000181Canonical exit: 25 Sept 2024 (T+90)
- ShareKRXDART:20240626000120Canonical exit: 24 Sept 2024 (T+90)
- ShareKRXDART:20240625000156Canonical exit: 23 Sept 2024 (T+90)
- 37,500 sharesKRXDART:20240624000075
- ●Executives0DART
25 of 82 declarations
About Raphas Co., Ltd.
The company 라파스 operates in the healthcare and pharmaceutical sector. It is listed on the XKRX market.
